These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7223886)

  • 21. Effect of PTH and 1,25(OH)2D3 on renal 25(OH)D3 metabolism, adenylate cyclase, and protein kinase.
    Armbrecht HJ; Wongsurawat N; Zenser TV; Davis BB
    Am J Physiol; 1984 Jan; 246(1 Pt 1):E102-7. PubMed ID: 6320659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of heparin on cortical adenylate cyclase activity and on urinary excretion of 3',5'-adenosine monophosphate in rat.
    Katzir Z; Wald H; Rubinger D; Popovtzer MM
    Miner Electrolyte Metab; 1989; 15(6):326-31. PubMed ID: 2482435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of thyroparathyroidectomy of calcium metabolism in rats: role of 1,25-dihydroxyvitamin D3.
    Rizzoli R; Fleisch H; Bonjour JP
    Am J Physiol; 1977 Sep; 233(3):E160-4. PubMed ID: 910902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Light- and electron-microscopic evaluation of the effects of 1,25-dihydroxyvitamin D3 on bone of thyroparathyroidectomized rats.
    Weisbrode SE; Capen CC; Norman AW
    Am J Pathol; 1979 Nov; 97(2):247-60. PubMed ID: 525673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human parathyroid hormone inhibits renal 24-hydroxylase activity of 25-hydroxyvitamin D3 by a mechanism involving adenosine 3',5'-monophosphate in rats.
    Shigematsu T; Horiuchi N; Ogura Y; Miyahara T; Suda T
    Endocrinology; 1986 Apr; 118(4):1583-9. PubMed ID: 3004922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The acute effect of 25-hydroxycholecalciferol on renal handling of phosphorus. Evidence for a parathyroid hormone-dependent mechanism.
    Popovtzer MM; Robinette JB; DeLuca HF; Holick MF
    J Clin Invest; 1974 Mar; 53(3):913-21. PubMed ID: 4812447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoradiographic studies with 3H 1,25 (OH)2 vitamin D2 and 3H 25 (OH) vitamin D3 in rat parathyroid glands.
    Stumpf WE; Sar M; Reid FA; Huang S; Narbaitz R; DeLuca HF
    Cell Tissue Res; 1981; 221(2):333-8. PubMed ID: 6895484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary excretion of cyclic AMP in cadmium-intoxicated rats.
    Ando M; Matsui S; Jinno H; Takeda M
    J Toxicol Environ Health; 1989; 27(3):307-15. PubMed ID: 2547079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for interference of vitamin D with PTH/PTHrP receptor expression in opossum kidney cells.
    Wald H; Dranitzki-Elhalel M; Backenroth R; Popovtzer MM
    Pflugers Arch; 1998 Jul; 436(2):289-94. PubMed ID: 9594030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-receptors in resistance to phosphaturic effect of PTH in respiratory alkalosis.
    Hoppe A; Rybczyńska A; Knox FG; Angielski S
    Am J Physiol; 1988 Oct; 255(4 Pt 2):R557-62. PubMed ID: 2845820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rat renal 25-hydroxyvitamin D3 1- and 24-hydroxylases: their in vivo regulation.
    Tanaka Y; DeLuca HF
    Am J Physiol; 1984 Feb; 246(2 Pt 1):E168-73. PubMed ID: 6538071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of insulin on renal phosphorus handling in the rat: interaction with PTH and nicotinamide.
    Guntupalli J; Rogers A; Bourke E
    Am J Physiol; 1985 Oct; 249(4 Pt 2):F610-8. PubMed ID: 2996369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced sensitivity of the hepatic adenylate cyclase-cyclic AMP system to glucagon during sustained hormonal stimulation.
    DeRubertis FR; Craven P
    J Clin Invest; 1976 Feb; 57(2):435-43. PubMed ID: 176180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conversion of 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 in renal slices from the rat.
    Armbrecht HJ; Zenser TV; Davis BB
    Endocrinology; 1981 Jul; 109(1):218-22. PubMed ID: 6972300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D3 metabolite injections to thyroparathyroidectomized pregnant rats: effects on calcium-binding proteins of maternal duodenum and of fetoplacental unit.
    Garel JM; Delorme AC; Marche P; Nguyen TM; Garabedian M
    Endocrinology; 1981 Jul; 109(1):284-9. PubMed ID: 6263587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphatemic action of 1,25-dihydroxyvitamin D3.
    Steele TH; Engle JE; Tanaka Y; Lorenc RS; Dudgeon KL; DeLuca HF
    Am J Physiol; 1975 Aug; 229(2):489-95. PubMed ID: 1163676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The vitamin D prodrugs 1alpha(OH)D2, 1alpha(OH)D3 and BCI-210 suppress PTH secretion by bovine parathyroid cells.
    Brown AJ; Ritter CS; Knutson JC; Strugnell SA
    Nephrol Dial Transplant; 2006 Mar; 21(3):644-50. PubMed ID: 16221703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1alpha-hydroxyvitamin D2 is less toxic but not bone selective relative to 1alpha-hydroxyvitamin D3 in ovariectomized rats.
    Weber K; Goldberg M; Stangassinger M; Erben RG
    J Bone Miner Res; 2001 Apr; 16(4):639-51. PubMed ID: 11315991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal adenylate cyclase and the interrelationship between parathyroid hormone and vitamin D in the regulation of urinary phosphate and adenosine cyclic 3',5'-monophosphate excretion.
    Forte LR; Nickols GA; Anast CS
    J Clin Invest; 1976 Mar; 57(3):559-68. PubMed ID: 175088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.